Baidu
map

2018 ASRA循证指南:接受抗栓或溶栓治疗患者进行区域阻滞麻醉(第4版)

2018-03-20 美国区域麻醉和疼痛医学学会 Reg Anesth Pain Med. 2018 Apr;43(3):263-309.

2018年美国区域麻醉和疼痛医学学会(ASRA)更新发布了接受抗栓或溶栓治疗患者进行区域阻滞麻醉管理指南第4版。围术期血栓栓塞的预防以及越来越多抗栓药物的应用导致椎管内麻醉出血的风险增加,本文是对2010年第2版指南的更新。文章主要建议主要供麻醉医生和其他提供椎管内麻醉或操作的临床医生应用。

中文标题:

2018 ASRA循证指南:接受抗栓或溶栓治疗患者进行区域阻滞麻醉(第4版)

英文标题:

Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Fourth Edition).

发布日期:

2018-03-20

简要介绍:

2018年美国区域麻醉和疼痛医学学会(ASRA)更新发布了接受抗栓或溶栓治疗患者进行区域阻滞麻醉管理指南第4版。围术期血栓栓塞的预防以及越来越多抗栓药物的应用导致椎管内麻醉出血的风险增加,本文是对2010年第2版指南的更新。文章主要建议主要供麻醉医生和其他提供椎管内麻醉或操作的临床医生应用。

 

拓展指南:麻醉相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 ASRA循证指南:接受抗栓或溶栓治疗患者进行区域阻滞麻醉(第4版))] GetToolGuiderByIdResponse(projectId=1, id=5a7681c0015e21f3, title=2018 ASRA循证指南:接受抗栓或溶栓治疗患者进行区域阻滞麻醉(第4版), enTitle=Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Fourth Edition)., guiderFrom=Reg Anesth Pain Med. 2018 Apr;43(3):263-309., authorId=null, author=, summary=2018年美国区域麻醉和疼痛医学学会(ASRA)更新发布了接受抗栓或溶栓治疗患者进行区域阻滞麻醉管理指南第4版。围术期血栓栓塞的预防以及越来越多抗栓药物的应用导致椎管内麻醉出血的风险增加,本文是对2010年第2版指南的更新。文章主要建议主要供麻醉医生和其他提供椎管内麻醉或操作的临床医生应用。 , cover=, journalId=null, articlesId=null, associationId=280, associationName=美国区域麻醉和疼痛医学学会, associationIntro=美国区域麻醉学会( American Society of Regional Anesthesia)成立于1923年8月2日,并于1939年与ASA合并,新的学会(ASRA)于1975年重组成为最大的专业麻醉学会,吸引了各个地区包括医生跟科学家在内的5500多名会员加入。, copyright=0, guiderPublishedTime=Tue Mar 20 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>2018年美国区域麻醉和疼痛医学学会(ASRA)更新发布了接受抗栓或溶栓治疗患者进行区域阻滞麻醉管理指南第4版。围术期血栓栓塞的预防以及越来越多抗栓药物的应用导致椎管内麻醉出血的风险增加,本文是对2010年第2版指南的更新。文章主要建议主要供麻醉医生和其他提供椎管内麻醉或操作的临床医生应用。 </P> <P> </P>拓展指南:<strong>与<font color=red>麻醉</font>相关指南:</strong><br><ul><li><a href="//www.sandwebs.com/guideline/show_article.do?id=142dc1c001569a1b" title="2017 ASRA实践建议:局部麻醉药全身毒性" target=_blank>2017 ASRA实践建议:局部麻醉药全身毒性</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=03ede1c00156091e" title="Stanford A型主动脉夹层外科手术麻醉中国专家临床路径管理共识(2017)" target=_blank>Stanford A型主动脉夹层外科手术麻醉中国专家临床路径管理共识(2017)</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=54d961c0015a1e9c" title="2017 ASGE指南:胃肠内镜检查的镇静和麻醉" target=_blank>2017 ASGE指南:胃肠内镜检查的镇静和麻醉</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=df94e1c001538547" title="美国心律学会和美国麻醉医师学会关于心血管植入型电子器械患者围术期处理专家共识解读" target=_blank>美国心律学会和美国麻醉医师学会关于心血管植入型电子器械患者围术期处理专家共识解读</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=bda651c001535ec9" title="加拿大麻醉医师学会:麻醉实践指南(2018修订版)" target=_blank>加拿大麻醉医师学会:麻醉实践指南(2018修订版)</a></li> 更多信息请点击:<a href="//www.sandwebs.com/guideline/list.do?q=%E9%BA%BB%E9%86%89" target=_blank>有关麻醉更多指南</a></ul>, tagList=[TagDto(tagId=56535, tagName=区域麻醉), TagDto(tagId=8411, tagName=局部麻醉)], categoryList=[CategoryDto(categoryId=29, categoryName=麻醉疼痛科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=15587, appHits=316, showAppHits=0, pcHits=5447, showPcHits=10783, likes=121, shares=10, comments=4, approvalStatus=1, publishedTime=Mon Mar 26 22:13:25 CST 2018, publishedTimeString=2018-03-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Mar 26 22:13:25 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 07:04:37 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 ASRA循证指南:接受抗栓或溶栓治疗患者进行区域阻滞麻醉(第4版))])
2018 ASRA循证指南:接受抗栓或溶栓治疗患者进行区域阻滞麻醉(第4版)
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1055869, encodeId=c7f5105586904, content=想要学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/c4a2f0cf055e4bc8bb3970902a633d4c/150e8482ab7446959f44f9c8dd6e022c.jpg, createdBy=19d75217845, createdName=1477308bm10(暂无昵称), createdTime=Tue Sep 28 23:35:56 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954254, encodeId=de70954254f2, content=真不错 有翻译好的么, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c235477437, createdName=ms6000000061379890, createdTime=Tue Apr 06 18:33:31 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301239, encodeId=8bca3012390b, content=学习学习吧, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Fri Mar 30 19:43:38 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300910, encodeId=920130091040, content=非常不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzXprUCFDMuY1SXH96r8MdtExF6fhSNLulicdUBcsodicYROXqf5icqDWFAOicfEqYtDcjL6HvrQrvmO1/0, createdBy=db841700299, createdName=克勤, createdTime=Thu Mar 29 19:13:34 CST 2018, time=2018-03-29, status=1, ipAttribution=)]
    2021-09-28 1477308bm10(暂无昵称)

    想要学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1055869, encodeId=c7f5105586904, content=想要学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/c4a2f0cf055e4bc8bb3970902a633d4c/150e8482ab7446959f44f9c8dd6e022c.jpg, createdBy=19d75217845, createdName=1477308bm10(暂无昵称), createdTime=Tue Sep 28 23:35:56 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954254, encodeId=de70954254f2, content=真不错 有翻译好的么, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c235477437, createdName=ms6000000061379890, createdTime=Tue Apr 06 18:33:31 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301239, encodeId=8bca3012390b, content=学习学习吧, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Fri Mar 30 19:43:38 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300910, encodeId=920130091040, content=非常不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzXprUCFDMuY1SXH96r8MdtExF6fhSNLulicdUBcsodicYROXqf5icqDWFAOicfEqYtDcjL6HvrQrvmO1/0, createdBy=db841700299, createdName=克勤, createdTime=Thu Mar 29 19:13:34 CST 2018, time=2018-03-29, status=1, ipAttribution=)]
    2021-04-06 ms6000000061379890

    真不错 有翻译好的么

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1055869, encodeId=c7f5105586904, content=想要学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/c4a2f0cf055e4bc8bb3970902a633d4c/150e8482ab7446959f44f9c8dd6e022c.jpg, createdBy=19d75217845, createdName=1477308bm10(暂无昵称), createdTime=Tue Sep 28 23:35:56 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954254, encodeId=de70954254f2, content=真不错 有翻译好的么, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c235477437, createdName=ms6000000061379890, createdTime=Tue Apr 06 18:33:31 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301239, encodeId=8bca3012390b, content=学习学习吧, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Fri Mar 30 19:43:38 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300910, encodeId=920130091040, content=非常不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzXprUCFDMuY1SXH96r8MdtExF6fhSNLulicdUBcsodicYROXqf5icqDWFAOicfEqYtDcjL6HvrQrvmO1/0, createdBy=db841700299, createdName=克勤, createdTime=Thu Mar 29 19:13:34 CST 2018, time=2018-03-29, status=1, ipAttribution=)]
    2018-03-30 易水河

    学习学习吧

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1055869, encodeId=c7f5105586904, content=想要学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/c4a2f0cf055e4bc8bb3970902a633d4c/150e8482ab7446959f44f9c8dd6e022c.jpg, createdBy=19d75217845, createdName=1477308bm10(暂无昵称), createdTime=Tue Sep 28 23:35:56 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954254, encodeId=de70954254f2, content=真不错 有翻译好的么, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c235477437, createdName=ms6000000061379890, createdTime=Tue Apr 06 18:33:31 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301239, encodeId=8bca3012390b, content=学习学习吧, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Fri Mar 30 19:43:38 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300910, encodeId=920130091040, content=非常不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzXprUCFDMuY1SXH96r8MdtExF6fhSNLulicdUBcsodicYROXqf5icqDWFAOicfEqYtDcjL6HvrQrvmO1/0, createdBy=db841700299, createdName=克勤, createdTime=Thu Mar 29 19:13:34 CST 2018, time=2018-03-29, status=1, ipAttribution=)]
    2018-03-29 克勤

    非常不错

    0

Baidu
map
Baidu
map
Baidu
map